A reason for this is that tumor-associated macrophages (TAMs) belong to the M2 immunomodulatory phenotype, exhibiting an increased expression of metalloprotease-9 and vascular endothelial growth factor (VEGF). The gene discussed is VEGFA; the disease is neoplasm.